Potential genetic link between type I diabetes and Parkinson’s disease.
Objective: To examine whether type 1 diabetes (T1D) is genetically or causally associated with Parkinson’s disease (PD). Background: Previous epidemiological and mendelian randomization studies demonstrated…Сlinical neurological features of diabetic and non-diabetic patients with Parkinson’s disease.
Objective: In the last decade, attention has been focused on the relationship between neurodegeneration and abnormal insulin signaling in the central nervous system, insulin in…Diabetic striatopathy presenting without hyperkinetic movements
Objective: To demonstrate a case of Diabetic striatopathy presenting without hyperkinetic movements Background: Diabetic striatopathy is an uncommon neurological complication associated with poorly controlled Diabetes Mellitus…Hemichorea syndrome secondary to diabetic striatopathy with contralateral drug-induced parkinsonism: a different threshold for drug induced movement disorders?
Objective: Localized structural damages could impair the threshold of activation and/or inhibition of the nigrostriatal pathway with a mirrored effect on the healthy and pathological…Acute Hyperglycemia Without Ketosis Related Movement Disorders: A Case Series
Objective: report 2 patients with different types of movement disorders (MD) revealing an Acute hyperglycemia without ketosis (AHWK). Background: neurological complications of diabetes are multiple,…A 69-year-old man with seizure-like activity and unresponsiveness
Objective: Highlight the clinical features and radiologic findings of diabetic striatopathy. Background: Diabetic striatopathy is a rare condition associated with chorea and/or ballism but can…Type 2 diabetes mellitus may worsen severity of motor symptoms in people with Parkinson’s disease
Objective: We aimed to determine whether co-morbid type 2 diabetes mellitus (T2DM) would impact the motor or non-motor symptom severity in people with Parkinson’s (PwP).…Unraveling the role of amylin oligomers in synucleinopathies
Objective: The aim of this work is to elucidate the role of amylin in both alpha-synuclein amyloid formation and Parkinson’s disease (PD) and dementia with…A Fluctuating Qualitative Dermatoglyphic Trait, Dankmeijer’s and Furuhata’s Index as a Risk Marker in Diabetic Parkinson’s Patients of Guyana: A Case-Control Study
Objective: The current study aims to compare and evaluate the fluctuating qualitative dermatoglyphic trait, Furuhata’s and Dankmeijer’s index as a risk marker in Diabetes and…Metabolic syndrome and insulin resistance in Parkinson’s disease: could they affect motor or cognitive symptoms?
Objective: The objective of this work was to detect the markers of metabolic syndrome and insulin resistance in patients with PD and to study their…